BRAF and undifferentiated carcinoma: Although BCPAP is a classic tool for studying BRAF V600E mutation-positive thyroid cancer, it cannot represent the high heterogeneity of thyroid cancer, including different pathological subtypes (such as follicular carcinoma, anaplastic carcinoma) and individual differences between patients.